← FDA Drug Approvals (Drugs@FDA)

LENALIDOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-09-12

Drug application

FDA Application #
ANDA210154
Application type
Abbreviated New Drug Application (Generic)
Brand name
LENALIDOMIDE
Generic name
LENALIDOMIDE
Active ingredients
LENALIDOMIDE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
ZYDUS PHARMS
Manufacturer
Zydus Pharmaceuticals USA Inc.
First approval
2022-09-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown